Drug Resistant Malaria Due to Plasmodium Falciparum Recruiting Phase 4 Trials for Artesunate (DB09274)

IndicationStatusPhase
DBCOND0077119 (Drug Resistant Malaria Due to Plasmodium Falciparum)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02604966P. Falciparum Resistance to Artemisinin in VietnamTreatment